JP2022505987A5 - - Google Patents
Info
- Publication number
- JP2022505987A5 JP2022505987A5 JP2021523157A JP2021523157A JP2022505987A5 JP 2022505987 A5 JP2022505987 A5 JP 2022505987A5 JP 2021523157 A JP2021523157 A JP 2021523157A JP 2021523157 A JP2021523157 A JP 2021523157A JP 2022505987 A5 JP2022505987 A5 JP 2022505987A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- haloalkyl
- heterocycloalkyl
- cycloalkyl
- ome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025017826A JP2025090577A (ja) | 2018-10-22 | 2025-02-05 | Tyk2阻害剤およびその使用 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862749003P | 2018-10-22 | 2018-10-22 | |
| US62/749,003 | 2018-10-22 | ||
| US201862756942P | 2018-11-07 | 2018-11-07 | |
| US62/756,942 | 2018-11-07 | ||
| US201962839459P | 2019-04-26 | 2019-04-26 | |
| US62/839,459 | 2019-04-26 | ||
| US201962875449P | 2019-07-17 | 2019-07-17 | |
| US62/875,449 | 2019-07-17 | ||
| US201962893721P | 2019-08-29 | 2019-08-29 | |
| US62/893,721 | 2019-08-29 | ||
| US201962907354P | 2019-09-27 | 2019-09-27 | |
| US62/907,354 | 2019-09-27 | ||
| PCT/US2019/057485 WO2020086616A1 (en) | 2018-10-22 | 2019-10-22 | Tyk2 inhibitors and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025017826A Division JP2025090577A (ja) | 2018-10-22 | 2025-02-05 | Tyk2阻害剤およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505987A JP2022505987A (ja) | 2022-01-14 |
| JP2022505987A5 true JP2022505987A5 (cg-RX-API-DMAC7.html) | 2022-10-28 |
| JP7631193B2 JP7631193B2 (ja) | 2025-02-18 |
Family
ID=70330735
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523157A Active JP7631193B2 (ja) | 2018-10-22 | 2019-10-22 | Tyk2阻害剤およびその使用 |
| JP2025017826A Pending JP2025090577A (ja) | 2018-10-22 | 2025-02-05 | Tyk2阻害剤およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025017826A Pending JP2025090577A (ja) | 2018-10-22 | 2025-02-05 | Tyk2阻害剤およびその使用 |
Country Status (26)
Families Citing this family (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3601268T (lt) * | 2017-03-30 | 2021-05-25 | Bristol-Myers Squibb Company | 6-(ciklopropanamido)-4-((2-metoksi-3-(1-metil-1h-1,2,4-triazol-3-il)fenil)amino)-n-(metil-d3)piridazino-3-karboksamido gavimo būdas |
| RS66346B1 (sr) | 2018-10-22 | 2025-01-31 | Alumis Inc | Inhibitori tyk2 i njihova upotreba |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
| BR112021013924A2 (pt) | 2019-01-18 | 2021-09-21 | Astrazeneca Ab | Inibidores de pcsk9 e métodos de uso do mesmo |
| CN111484480B (zh) * | 2019-01-29 | 2023-08-11 | 上海翰森生物医药科技有限公司 | 一种多环类衍生物抑制剂、其制备方法和应用 |
| WO2020159904A1 (en) * | 2019-01-30 | 2020-08-06 | Bristol-Myers Squibb Company | Amide-disubstituted pyridine or pyridazine compounds |
| KR102865925B1 (ko) * | 2019-03-05 | 2025-09-26 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물 |
| US12528782B2 (en) | 2019-07-16 | 2026-01-20 | Bristol-Myers Squibb Company | Prodrugs in the modulation of interleukin |
| AU2020315401B2 (en) | 2019-07-16 | 2025-05-22 | The Regents Of The University Of Michigan | Imidazopyrimidines as EED inhibitors and the use thereof |
| CN114846012B (zh) | 2019-09-27 | 2024-01-26 | 武田药品工业株式会社 | 可用作hdac6抑制剂的2-异吲哚-1,3,4-噁二唑衍生物 |
| US12606556B2 (en) | 2020-02-26 | 2026-04-21 | Beone Medicines I Gmbh | TYK-2 inhibitor |
| ES2981764T3 (es) * | 2020-03-11 | 2024-10-10 | Beijing Innocare Pharma Tech Co Ltd | Compuestos heterocíclicos para inhibir las actividades de TYK2 |
| WO2021202652A1 (en) * | 2020-04-01 | 2021-10-07 | Eternity Bioscience Inc. | Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereof |
| US20230295119A1 (en) * | 2020-04-14 | 2023-09-21 | Gossamer Bio Services, Inc. | Substituted pyridines for the treatment of inflammatory diseases |
| CN113563309B (zh) * | 2020-04-28 | 2024-12-13 | 浙江海正药业股份有限公司 | 吡啶类衍生物及其制备方法和用途 |
| CN113735837B (zh) * | 2020-05-28 | 2023-09-01 | 江苏先声药业有限公司 | 哒嗪类化合物及其用途 |
| CN113735836B (zh) * | 2020-05-28 | 2023-05-30 | 江苏先声药业有限公司 | 哒嗪类化合物及其应用 |
| CN113773262B (zh) * | 2020-06-09 | 2024-08-09 | 江苏先声药业有限公司 | 哒嗪类化合物 |
| US20240043435A1 (en) | 2020-06-22 | 2024-02-08 | Beigene, Ltd. | Tyk-2 inhibitor |
| CN114057651B (zh) * | 2020-07-31 | 2025-05-27 | 正大天晴药业集团股份有限公司 | 含酰胺基的tyk2抑制剂化合物 |
| WO2022032484A1 (zh) * | 2020-08-11 | 2022-02-17 | 北京诺诚健华医药科技有限公司 | 哒嗪-3-甲酰胺类化合物、其制备方法及其在医药学上的应用 |
| WO2022033544A1 (zh) * | 2020-08-13 | 2022-02-17 | 广东东阳光药业有限公司 | 取代的杂芳基化合物及其组合物和用途 |
| CN114075220A (zh) * | 2020-08-13 | 2022-02-22 | 广东东阳光药业有限公司 | 取代的杂芳基化合物及其组合物和用途 |
| IL301385A (en) | 2020-09-16 | 2023-05-01 | Alumis Inc | TYK2 inhibitors and their use |
| TW202227430A (zh) * | 2020-11-17 | 2022-07-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 含氮雜環類衍生物、其製備方法及其在醫藥上的應用 |
| TWI912419B (zh) * | 2020-12-02 | 2026-01-21 | 大陸商深圳微芯生物科技股份有限公司 | 羥肟酸酯化合物、其製備方法及其應用 |
| CN116547276A (zh) * | 2020-12-08 | 2023-08-04 | 正大天晴药业集团股份有限公司 | 含酰胺基和杂环烷基的tyk2抑制剂化合物 |
| CN122520625A (zh) * | 2020-12-22 | 2026-08-07 | 益方生物科技(上海)股份有限公司 | 杂芳基化合物及其制备方法和用途 |
| US12668594B2 (en) | 2020-12-23 | 2026-06-30 | Sudo Biosciences Limited | TYK2 inhibitors and uses thereof |
| IL305119A (en) | 2021-02-19 | 2023-10-01 | Sudo Biosciences Ltd | Tyk2 inhibitors and uses thereof |
| TW202302583A (zh) | 2021-02-19 | 2023-01-16 | 英商蘇多生物科學有限公司 | Tyk2抑制劑及其用途 |
| KR20230159421A (ko) | 2021-02-19 | 2023-11-21 | 수도 바이오사이언시즈 리미티드 | Tyk2 억제제 및 이의 용도 |
| WO2022179578A1 (zh) * | 2021-02-24 | 2022-09-01 | 南京明德新药研发有限公司 | 含有亚磺酰基吡啶结构的化合物以及应用 |
| CN112920103A (zh) * | 2021-03-02 | 2021-06-08 | 康化(上海)新药研发有限公司 | 一种温和制备2-氮杂螺[3.3]庚烷盐酸盐的方法 |
| EP4308556A4 (en) * | 2021-03-16 | 2025-02-19 | Anrui Biomedical Technology (Guangzhou) Co., Ltd. | Amino heteroaryl compounds and compositions |
| CN115197196B (zh) * | 2021-04-06 | 2024-06-18 | 扬子江药业集团有限公司 | Tyk2抑制剂及其用途 |
| CN116888125B (zh) * | 2021-04-07 | 2024-04-12 | 上海齐鲁制药研究中心有限公司 | Tyk2抑制剂及其用途 |
| JP7740849B2 (ja) * | 2021-05-04 | 2025-09-17 | シャンハイ ゼイ バイオテクノロジー カンパニー リミテッド | 含窒素複素環ピリジン化合物 |
| KR20240008338A (ko) * | 2021-05-14 | 2024-01-18 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 헤테로시클릭 화합물 |
| EP4337650A1 (en) * | 2021-05-14 | 2024-03-20 | Bristol-Myers Squibb Company | Substituted heterocyclic compounds |
| WO2022253333A1 (zh) * | 2021-06-02 | 2022-12-08 | 南京明德新药研发有限公司 | 酰胺类化合物及其应用 |
| WO2022253335A1 (zh) * | 2021-06-02 | 2022-12-08 | 南京明德新药研发有限公司 | 含磺酰基的芳基类化合物及其应用 |
| CN115466289B (zh) * | 2021-06-11 | 2026-07-03 | 爱科诺生物医药(苏州)有限公司 | 具有tyk2抑制活性的化合物,包含其的药物组合物,及其应用 |
| CA3223641A1 (en) * | 2021-06-22 | 2022-12-29 | Wenyuan Qian | Sulfoximine compound and use thereof |
| CN117794911A (zh) * | 2021-07-15 | 2024-03-29 | 南京明德新药研发有限公司 | 含硫/磷的芳基类化合物及其应用 |
| TW202320786A (zh) * | 2021-08-10 | 2023-06-01 | 美商蕾瑞拉股份有限公司 | 用於毛髮治療的組合物、調配物及方法 |
| CN115724830A (zh) * | 2021-08-31 | 2023-03-03 | 浙江文达医药科技有限公司 | 作为tyk2/jak1假激酶结构域(jh2)抑制剂的化合物及合成和使用方法 |
| EP4410806A1 (en) * | 2021-09-30 | 2024-08-07 | ASKA Pharmaceutical Co., Ltd. | Degradation inducer |
| WO2023064223A1 (en) * | 2021-10-11 | 2023-04-20 | Gossamer Bio Services, Inc. | Tri-substituted pyridines |
| KR20240111312A (ko) | 2021-10-25 | 2024-07-16 | 카이메라 쎄라퓨틱스 인코포레이티드 | Tyk2 분해제 및 이의 용도 |
| TW202339749A (zh) * | 2021-12-16 | 2023-10-16 | 大陸商凌科藥業有限公司 | Tyk2抑制劑及其組合物和方法 |
| US20250051360A1 (en) * | 2021-12-23 | 2025-02-13 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compound, and composition and use thereof |
| MX2024007713A (es) * | 2021-12-23 | 2024-07-01 | Beigene Switzerland Gmbh | Formas solidas de un inhibidor de tyk2, metodo de preparacion y uso de estas. |
| CN116693449A (zh) | 2022-03-04 | 2023-09-05 | 上海致根医药科技有限公司 | 用作tyk2抑制剂的化合物、其制备方法及其在医药上的应用 |
| TW202342000A (zh) | 2022-03-29 | 2023-11-01 | 美商雅盧米斯公司 | Tyk2抑制劑及其用途 |
| US20260209205A1 (en) * | 2022-05-13 | 2026-07-23 | Alumis Inc. | Crystalline forms of a tyk2 inhibitor and uses thereof |
| AU2023283927A1 (en) * | 2022-06-07 | 2024-08-15 | Guangzhou Fermion Technology Co., Ltd. | Substituted pyridazine-3-carboxamide compound serving as tyk2 inhibitor |
| WO2023236945A1 (zh) * | 2022-06-07 | 2023-12-14 | 广州费米子科技有限责任公司 | 哒嗪-3-甲酰胺化合物作为tyk2抑制剂 |
| AU2023294765A1 (en) * | 2022-06-17 | 2024-12-12 | Sundance Biosciences, Inc. | Kinase modulators and methods of use thereof |
| CN120661462B (zh) * | 2022-06-20 | 2026-05-26 | 益方生物科技(上海)股份有限公司 | 药物组合物及其用途 |
| CN117263913A (zh) | 2022-06-20 | 2023-12-22 | 益方生物科技(上海)股份有限公司 | 杂芳基化合物、固体形式、制备方法及其用途 |
| US20250376459A1 (en) * | 2022-09-12 | 2025-12-11 | Alumis Inc. | Crystalline forms of a tyk2 inhibitor and uses thereof |
| TW202428571A (zh) * | 2022-10-10 | 2024-07-16 | 美商雅盧米斯公司 | Tyk2抑制劑之晶型及其用途 |
| US12251459B2 (en) | 2022-10-12 | 2025-03-18 | Oddity Labs, Llc | Compositions, formulations, and methods for hair treatment |
| CN120152968A (zh) * | 2022-11-08 | 2025-06-13 | 百时美施贵宝公司 | 取代的杂环化合物 |
| WO2024123668A1 (en) * | 2022-12-05 | 2024-06-13 | Oddity Labs, Llc | Compositions, formulations, and methods for hair treatment |
| TW202430168A (zh) | 2022-12-16 | 2024-08-01 | 印度商阿蘭比克製藥有限公司 | Tyk2假激酶配體及其用途 |
| CN116284040B (zh) * | 2023-01-05 | 2024-05-28 | 华润医药研究院(深圳)有限公司 | 含氮杂环类化合物及其医药用途 |
| WO2024173764A1 (en) | 2023-02-16 | 2024-08-22 | Alumis Inc. | Methods of treating hidradenitis suppurativa |
| WO2024257023A1 (en) * | 2023-06-14 | 2024-12-19 | Alembic Pharmaceuticals Limited | Tyk2 pseudokinase ligands and uses thereof |
| CN121909018A (zh) | 2023-09-20 | 2026-04-21 | 阿鲁米斯公司 | Tyk2抑制剂的立即释放制剂 |
| WO2025186427A1 (en) | 2024-03-08 | 2025-09-12 | Curia Spain, S.A.U. | Process for the preparation of deucravacitinib and intermediates thereof and method for purifying deucravacitinib |
| WO2025194074A1 (en) * | 2024-03-15 | 2025-09-18 | Neuron23, Inc. | Kinase modulators and methods of use thereof |
| WO2025240835A2 (en) * | 2024-05-17 | 2025-11-20 | Prelude Therapeutics Incorporated | Jak2 inhibitors and their use as pharmaceuticals |
| WO2026019902A1 (en) * | 2024-07-16 | 2026-01-22 | Alumis Inc. | Crystalline forms of a tyk2 inhibitor and uses thereof |
| TW202610624A (zh) * | 2024-07-16 | 2026-03-16 | 美商雅盧米斯公司 | Tyk2抑制劑之晶型及其用途 |
| WO2026026866A1 (zh) * | 2024-08-02 | 2026-02-05 | 北京普祺医药科技股份有限公司 | 作为tyk2抑制剂的大环化合物及其药物组合物 |
| WO2026092538A1 (zh) * | 2024-10-29 | 2026-05-07 | 上海喆邺生物科技有限公司 | 含氮杂环类衍生物在制备治疗皮肤病药物中的用途 |
| WO2026128621A2 (en) * | 2024-12-12 | 2026-06-18 | Alumis Inc. | Process of making tyk2 inhibitors and uses thereof |
| WO2026136251A1 (en) | 2024-12-16 | 2026-06-25 | Alumis Inc. | Tyk2 inhibitor for treating neuroinflammatory or neurodegenerative diseases |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1351691A4 (en) | 2000-12-12 | 2005-06-22 | Cytovia Inc | SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF |
| AU2003262642B2 (en) | 2002-08-14 | 2010-06-17 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors and uses thereof |
| US20060281763A1 (en) * | 2005-03-25 | 2006-12-14 | Axon Jonathan R | Carboxamide inhibitors of TGFbeta |
| US7517882B2 (en) | 2006-09-18 | 2009-04-14 | Polaris Group | Protein kinase inhibitors |
| KR20100132550A (ko) * | 2008-04-16 | 2010-12-17 | 포톨라 파마슈티컬스, 인코포레이티드 | syk 또는 JAK 키나제 억제제로서의 2,6-디아미노-피리미딘-5-일-카르복스아미드 |
| EP2361902A4 (en) | 2008-11-21 | 2012-04-25 | Astellas Pharma Inc | 4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG |
| MX2011011875A (es) * | 2009-05-08 | 2011-12-08 | Astellas Pharma Inc | Compuesto de carboxamida heterociclica diamino. |
| BR122019024201B1 (pt) | 2010-05-20 | 2021-08-03 | Array Biopharma Inc | Composto macrocíclico como inibidores de trk quinase, seu uso, e composição farmacêutica |
| EP2975027A1 (en) * | 2010-11-01 | 2016-01-20 | Portola Pharmaceuticals, Inc. | Nicotinamides as jak kinase modulators |
| AU2011323484B2 (en) * | 2010-11-01 | 2016-10-06 | Portola Pharmaceuticals, Inc. | Benzamides and nicotinamides as Syk modulators |
| CN102250065B (zh) | 2011-05-20 | 2015-05-13 | 浙江海正药业股份有限公司 | 取代的三嗪苯脲衍生物及其用途 |
| WO2013001310A1 (en) | 2011-06-30 | 2013-01-03 | Centro Nacional De Investigaciones Oncológicas (Cnio) | Macrocyclic compounds and their use as cdk8 inhibitors |
| PT2760453T (pt) | 2011-09-30 | 2016-08-02 | Ipsen Pharma Sas | Inibidores macrocíclicos da cinase lrrk2 |
| KR20140108594A (ko) * | 2012-01-10 | 2014-09-11 | 에프. 호프만-라 로슈 아게 | 피리다진 아미드 화합물 및 syk 저해제로서의 이의 용도 |
| HRP20220766T1 (hr) * | 2012-11-08 | 2022-09-16 | Bristol-Myers Squibb Company | Amidom-supstituirani heterociklički spojevi korisni kao modulatori il-12, il-23 i/ili ifn alfa odgovora |
| US9701689B2 (en) | 2012-11-30 | 2017-07-11 | Kyowa Hakko Kirin Co., Ltd. | Substituted pyridines and pyridazines as CCR10 receptor inhibitors |
| WO2014140299A1 (en) | 2013-03-15 | 2014-09-18 | Oncodesign S.A | Macrocyclic rip2 kinase inhibitors |
| JP6484555B2 (ja) * | 2013-08-29 | 2019-03-13 | 京都薬品工業株式会社 | 新規芳香族化合物およびその用途 |
| AR094537A1 (es) * | 2013-11-07 | 2015-08-12 | Bristol Myers Squibb Co | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA ÚTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL-23 Y/O IFNa |
| AU2014360446A1 (en) * | 2013-12-05 | 2016-06-09 | Pharmacyclics, Llc | Inhibitors of Bruton's tyrosine kinase |
| WO2015112806A2 (en) | 2014-01-24 | 2015-07-30 | Tp Therapeutics, Inc. | Diaryl macrocycles as modulators of protein kinases |
| WO2015123453A1 (en) * | 2014-02-14 | 2015-08-20 | Portola Pharmaceuticals, Inc. | Pyridazine compounds as jak inhibitors |
| CN105111151B (zh) | 2015-04-17 | 2018-09-28 | 成都理工大学 | 作为PPAR-γ调节剂的氨基嘧啶衍生物 |
| BR112017025986A2 (pt) * | 2015-06-02 | 2018-08-14 | Pharmacyclics Llc | inibidores de tirosina quinase de bruton. |
| RU2732405C2 (ru) | 2015-07-02 | 2020-09-16 | Тёрнинг Поинт Терапьютикс, Инк. | Хиральные диарильные макроциклы в качестве модуляторов протеинкиназ |
| BR112018000297A2 (pt) | 2015-07-06 | 2018-09-04 | Tp Therapeutics Inc | polimorfo de macrociclo de diarila |
| WO2017015367A1 (en) | 2015-07-21 | 2017-01-26 | Tp Therapeutics, Inc. | Chiral diaryl macrocycles and uses thereof |
| EP3368039A1 (en) | 2015-10-26 | 2018-09-05 | The Regents of The University of Colorado, A Body Corporate | Point mutations in trk inhibitor-resistant cancer and methods relating to the same |
| KR102782807B1 (ko) | 2015-11-18 | 2025-03-14 | 브리스톨-마이어스 스큅 컴퍼니 | Il-12, il-23 및/또는 ifn 알파 반응의 조정제로서 유용한 이미다조피리다진 화합물 |
| EP3405464B1 (en) | 2016-01-22 | 2019-12-04 | Janssen Pharmaceutica NV | New 6-membered heteroaromatic substituted cyanoindoline derivatives as nik inhibitors |
| AU2017302019A1 (en) | 2016-07-28 | 2019-02-07 | Turning Point Therapeutics, Inc. | Macrocycle kinase inhibitors |
| US10836770B2 (en) | 2016-10-07 | 2020-11-17 | Bristol-Myers Squibb Company | Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses |
| JOP20190092A1 (ar) | 2016-10-26 | 2019-04-25 | Array Biopharma Inc | عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها |
| WO2018112027A1 (en) | 2016-12-14 | 2018-06-21 | Development Center For Biotechnology | Antibody-drug conjugates and uses thereof |
| TWI808958B (zh) | 2017-01-25 | 2023-07-21 | 美商特普醫葯公司 | 涉及二芳基巨環化合物之組合療法 |
| CN106866660B (zh) | 2017-02-15 | 2019-05-17 | 上海天马有机发光显示技术有限公司 | 电子传输材料、包含其的oled显示面板和电子设备 |
| AU2018230737B2 (en) * | 2017-03-08 | 2022-09-22 | Takeda Pharmaceutical Company Limited | Tyk2 inhibitors, uses, and methods for production thereof |
| JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
| WO2018186366A1 (ja) | 2017-04-03 | 2018-10-11 | 京都薬品工業株式会社 | 新規サイクリン依存性キナーゼ8及び/又は19阻害剤 |
| WO2018234345A1 (en) | 2017-06-21 | 2018-12-27 | F. Hoffmann-La Roche Ag | PYRAZOLO [1,5A] PYRIMIDINE DERIVATIVES AS MODULATORS OF IRAK4 |
| PT3658148T (pt) | 2017-07-28 | 2024-08-26 | Turning Point Therapeutics Inc | Compostos macrocíclicos e utilizações dos mesmos |
| US10180422B1 (en) | 2017-08-22 | 2019-01-15 | Scripps Health | Methods of treating a neuroendocrine tumor |
| KR102619444B1 (ko) | 2017-08-23 | 2023-12-29 | 치아타이 티안큉 파마수티컬 그룹 주식회사 | 아미노피라졸 및 피리미딘을 함유하는 마크로사이클 및 그의 약학적 조성물 및 용도 |
| WO2019049891A1 (ja) | 2017-09-06 | 2019-03-14 | 小野薬品工業株式会社 | Trk阻害剤とキナーゼ阻害剤の併用による癌治療方法 |
| CA3080157A1 (en) | 2017-10-26 | 2019-05-02 | Array Biopharma Inc. | Formulations of a macrocyclic trk kinase inhibitor |
| WO2019084499A1 (en) | 2017-10-27 | 2019-05-02 | Genea Biocells USA (Holdings), Inc. | INHIBITORS OF DUX4 INDUCTION FOR REGULATION OF MUSCLE FUNCTION |
| CA3081790C (en) | 2017-11-10 | 2023-03-07 | Angex Pharmaceutical, Inc. | Macrocyclic compounds as trk kinase inhibitors and uses thereof |
| RS63787B1 (sr) | 2017-12-19 | 2022-12-30 | Turning Point Therapeutics Inc | Makrociklična jedinjenja za lečenje bolesti |
| WO2019144885A1 (zh) | 2018-01-23 | 2019-08-01 | 深圳市塔吉瑞生物医药有限公司 | 取代的吡唑并[1,5-a]嘧啶类的大环化合物 |
| WO2019165967A1 (zh) | 2018-02-28 | 2019-09-06 | 南京明德新药研发有限公司 | 吡唑并嘧啶衍生物及其用途 |
| EP3773725A1 (en) | 2018-03-29 | 2021-02-17 | Loxo Oncology Inc. | Treatment of trk-associated cancers |
| CN109053682B (zh) | 2018-07-27 | 2020-10-27 | 东南大学 | 一种tdo小分子抑制剂衍生物及其抗肿瘤偶联物和制备方法 |
| RS66346B1 (sr) | 2018-10-22 | 2025-01-31 | Alumis Inc | Inhibitori tyk2 i njihova upotreba |
| CA3126034A1 (en) | 2019-01-23 | 2020-07-30 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
| KR102943760B1 (ko) | 2019-01-28 | 2026-03-26 | 장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 | 피리다진 유도체 억제제, 및 그의 제조 방법 및 용도 |
| SG11202108619SA (en) | 2019-02-07 | 2021-09-29 | Ventyx Biosciences Inc | Tyk2 pseudokinase ligands |
| US20220177486A1 (en) | 2019-03-11 | 2022-06-09 | Esker Therapeutics, Inc. | Tyk2 inhibitors and uses thereof |
| SG11202110523XA (en) | 2019-03-26 | 2021-10-28 | Ventyx Biosciences Inc | Tyk2 pseudokinase ligands |
| CN114929226B (zh) | 2019-11-08 | 2024-09-27 | 温缇克斯生物科学公司 | Tyk2假激酶配体 |
-
2019
- 2019-10-22 RS RS20241445A patent/RS66346B1/sr unknown
- 2019-10-22 SM SM20260191T patent/SMT202600191T1/it unknown
- 2019-10-22 LT LTEPPCT/US2019/057485T patent/LT3870579T/lt unknown
- 2019-10-22 SM SM20250070T patent/SMT202500070T1/it unknown
- 2019-10-22 ES ES24203217T patent/ES3069897T3/es active Active
- 2019-10-22 KR KR1020217015306A patent/KR102850357B1/ko active Active
- 2019-10-22 HR HRP20260578TT patent/HRP20260578T1/hr unknown
- 2019-10-22 HR HRP20250048TT patent/HRP20250048T1/hr unknown
- 2019-10-22 LT LTEP24203217.5T patent/LT4480953T/lt unknown
- 2019-10-22 HU HUE19877015A patent/HUE070644T2/hu unknown
- 2019-10-22 CN CN201980084885.9A patent/CN113490664B/zh active Active
- 2019-10-22 PT PT242032175T patent/PT4480953T/pt unknown
- 2019-10-22 PT PT242032084T patent/PT4461734T/pt unknown
- 2019-10-22 DK DK24203217.5T patent/DK4480953T3/da active
- 2019-10-22 EP EP19877015.8A patent/EP3870579B1/en active Active
- 2019-10-22 MX MX2021004538A patent/MX2021004538A/es unknown
- 2019-10-22 SM SM20260190T patent/SMT202600190T1/it unknown
- 2019-10-22 LT LTEP24203208.4T patent/LT4461734T/lt unknown
- 2019-10-22 FI FIEP19877015.8T patent/FI3870579T3/fi active
- 2019-10-22 PL PL19877015.8T patent/PL3870579T3/pl unknown
- 2019-10-22 BR BR112021007679-4A patent/BR112021007679A2/pt unknown
- 2019-10-22 UA UAA202102676A patent/UA130518C2/uk unknown
- 2019-10-22 EP EP24203217.5A patent/EP4480953B1/en active Active
- 2019-10-22 JP JP2021523157A patent/JP7631193B2/ja active Active
- 2019-10-22 SI SI201930870T patent/SI3870579T1/sl unknown
- 2019-10-22 EP EP24203208.4A patent/EP4461734B1/en active Active
- 2019-10-22 RS RS20260501A patent/RS68048B1/sr unknown
- 2019-10-22 AU AU2019364336A patent/AU2019364336B2/en active Active
- 2019-10-22 FI FIEP24203217.5T patent/FI4480953T3/fi active
- 2019-10-22 HR HRP20260580TT patent/HRP20260580T1/hr unknown
- 2019-10-22 RS RS20260497A patent/RS68029B1/sr unknown
- 2019-10-22 ES ES19877015T patent/ES3011855T3/es active Active
- 2019-10-22 ES ES24203208T patent/ES3069896T3/es active Active
- 2019-10-22 FI FIEP24203208.4T patent/FI4461734T3/fi active
- 2019-10-22 DK DK24203208.4T patent/DK4461734T3/da active
- 2019-10-22 WO PCT/US2019/057485 patent/WO2020086616A1/en not_active Ceased
- 2019-10-22 DK DK19877015.8T patent/DK3870579T3/da active
- 2019-10-22 CA CA3117200A patent/CA3117200A1/en active Pending
- 2019-10-22 SI SI201931046T patent/SI4480953T1/sl unknown
- 2019-10-22 SG SG11202104017VA patent/SG11202104017VA/en unknown
- 2019-10-22 PL PL24203208.4T patent/PL4461734T3/pl unknown
- 2019-10-22 PT PT198770158T patent/PT3870579T/pt unknown
- 2019-10-22 SI SI201931047T patent/SI4461734T1/sl unknown
- 2019-10-22 EP EP26155703.7A patent/EP4763208A2/en active Pending
- 2019-10-22 PL PL24203217.5T patent/PL4480953T3/pl unknown
-
2020
- 2020-07-24 US US16/938,183 patent/US11053219B2/en active Active
-
2021
- 2021-04-20 CL CL2021000989A patent/CL2021000989A1/es unknown
- 2021-04-20 IL IL282487A patent/IL282487B2/en unknown
- 2021-04-21 SA SA521421806A patent/SA521421806B1/ar unknown
- 2021-04-28 US US17/243,508 patent/US12006306B2/en active Active
-
2022
- 2022-04-05 US US17/713,646 patent/US12060343B2/en active Active
- 2022-08-19 US US17/891,817 patent/US11731956B2/en active Active
-
2023
- 2023-06-15 US US18/335,262 patent/US12351572B2/en active Active
-
2025
- 2025-02-05 JP JP2025017826A patent/JP2025090577A/ja active Pending
- 2025-05-13 US US19/206,459 patent/US20260125361A1/en active Pending